Cargando…
Biosimilars: Opportunities to Promote Optimization Through Payer and Provider Collaboration
A panel was convened that consisted of 1 medical director, 2 pharmacy directors, and 2 oncologists, who represented the University of Pittsburgh Medical Center Health Plan, an integrated delivery network, and Florida Blue, a progressive regional health plan. This panel met in order to share ideas, d...
Autores principales: | Manolis, Chronis H., Rajasenan, Kiran, Harwin, William, McClelland, Scott, Lopes, Maria, Farnum, Carolyn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408397/ https://www.ncbi.nlm.nih.gov/pubmed/27579939 http://dx.doi.org/10.18553/jmcp.2016.22.9-a.s3 |
Ejemplares similares
-
Biosimilars: How Can Payers Get Long-Term Savings?
por: Mestre-Ferrandiz, Jorge, et al.
Publicado: (2016) -
Overcoming barriers to biosimilar adoption: real-world perspectives from a national payer and provider initiative
por: Edgar, Babette S, et al.
Publicado: (2021) -
Viscosupplementation for Osteoarthritis of the Knee: A Key Opinion Leader Panel Discussion
por: Bert, Jack, et al.
Publicado: (2018) -
Exploring the misalignment on the value of further research between payers and manufacturers. A case study on a novel total artificial heart
por: Federici, Carlo, et al.
Publicado: (2022) -
Abstract 101: Impact Of Insurance Payer On Type Of Breast Reconstruction Performed
por: Gabrick, Kyle, et al.
Publicado: (2019)